Live Quote · NASDAQINBXHealthcare· Biotechnology

Inhibrx Biosciences Inc.

$68.97▼ 7.21%($-5.36)
MKT CAP $1.02BNEXT EARNINGS Mar 18, 2027
50%
Bullish
TickerSpark Score
46/100
▌ Weak
30
Valuation
45
Profitability
55
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INBX research report →

Analyst Price Target
$245.00+255.2% vs. today

Range $245 – $245

Analyst RatingBuy
3 Buy2 Hold0 Sell

Price Chart

-13.61% · this period
$141.84$100.12$58.39Nov 20May 26Nov 20
52-Week Range12% of range
Low
$57.30
Current
$68.97
High
$155.29